Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11511313 | 0.87 | CA1 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9113536 | 0.85 | GRIA1 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2960326 | 0.85 | NFE2L2 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10992125 | 0.83 | GABRA1 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2676294 | 0.76 | TDP1 (0.41) | ALDH1A1CYP3A4HPGDMAPK1KDM4E | |
| SCHEMBL18245688 | 0.75 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2582337 | 0.75 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL4739158 | 0.75 | RAB9A (0.59) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2811725 | 0.75 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL2814633 | 0.75 | IRAK4 (0.44) | CA1CA2CA7CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 821 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347728-A1 | UV LED FREE RADICAL CURABLE INKJET INKS | AGFA NV (BE) | 2024-04-10 | — | — | EP | claimed |
| US-20240025931-A1 | Acylphosphine Oxide Photoinitiators and Applications Thereof | AGFA NV (BE) | 2024-01-25 | — | — | US | claimed |
| CN-117440994-A | UV LED free radical curable inkjet ink | 爱克发有限公司 | 2024-01-23 | — | — | CN | claimed |
| US-20230416547-A1 | UV Curable Inkjet Inks and Inkjet Printing Methods | AGFA NV (BE) | 2023-12-28 | — | — | US | claimed |
| WO-2023232305-A1 | INKJET PRINTING METHODS | AGFA NV (BE) | 2023-12-07 | — | — | WO | claimed |
| EP-4286483-A1 | INKJET PRINTING METHODS | AGFA NV (BE) | 2023-12-06 | — | — | EP | claimed |
| EP-4247824-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND APPLICATIONS THEREOF | AGFA NV (BE) | 2023-09-27 | — | — | EP | claimed |
| EP-4247903-A1 | UV CURABLE INKJET INKS AND INKJET PRINTING METHODS | AGFA NV (BE) | 2023-09-27 | — | — | EP | claimed |
| CN-116438189-A | Acyl phosphine oxide photoinitiator and application thereof | 爱克发有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116390929-A | UV curable inkjet inks and inkjet printing methods | 爱克发有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-4171438-A | 0-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1979-10-16 | — | — | US | claimed |
| US-4166905-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1979-09-04 | — | — | US | claimed |
| US-4166906-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1979-09-04 | — | — | US | claimed |
| US-4145343-A | BACTERICIDES | UCB SOCIETE ANONYME (BE) | 1979-03-20 | — | — | US | claimed |
| US-4139628-A | ANTIBIOTICS | U C B, SOCIETE ANONYME (BE) | 1979-02-13 | — | — | US | claimed |
| US-4118566-A | Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1978-10-03 | — | — | US | claimed |
| US-4113946-A | Δ2,3 -1,4-Morpholine-2-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1978-09-12 | — | — | US | claimed |
| US-4112230-A | Δ2,3 -1,4 Morpholine-2-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1978-09-05 | — | — | US | claimed |
| US-3984401-A | Process for producing lactol-type cephalosporins | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1976-10-05 | — | — | US | claimed |
| US-3966720-A | Process for producing desacetoxy cephalosporanic acid compound | NIKKEN CHEMICALS CO., LTD. (JA) | 1976-06-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025931-A1 | Acylphosphine Oxide Photoinitiators and Applications Thereof | DDO, PAM, SAT1 | CA1 1500/4885CA2 1340/4885CA7 1406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.